The U.S. Department of Health and Human Services said it would wind down mRNA vaccine development activities under its ...

(Reuters) -Novavax beat Wall Street expectations for second-quarter revenue on Wednesday, helped by a $175 million milestone ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.

Texas Gov. Abbott orders civil arrest of Democratic lawmakers who fled state How Do I Know If My Dog Is Happy? 12 Signs of a ...

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...

Twenty-two projects, totaling $500 million, to develop vaccines using mRNA technology will be halted, the health secretary ...

Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), the agency ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...